MAP4K3 and autoimmune disease: Furthermore, non-photoactivated VP also inhibited IL-17A production by the AhR-RORγt complex by targeting GLK, which is suggestive of a potential therapeutic effect against Th17-mediated autoimmune diseases (Chuang and Tan, 2019).